Dr. Frank Pun - Head of Hong Kong Office - INSILICO MEDICINE

Dr. Frank Pun is the Head of Insilico Hong Kong, where he leads a team of application scientists focused on AI-powered biological target discovery, indication expansion, and drug repurposing. His primary objective is to provide cutting-edge AI technology (Pharma.AI) to scientists and medical professionals worldwide, enabling them to identify actionable therapeutic targets and expedite drug discovery and development.

Frank received his Ph.D. in Biochemistry from the Hong Kong University of Science and Technology in 2010. Following his graduation, he served as a visiting scholar, leading a team dedicated to studying human CNS diseases and cancer for several years. In 2019, he also obtained an MBA from Rutgers Business School in the United States. Throughout his career, Frank has made significant contributions to target discovery, publishing numerous impactful papers in the field.